ADCT
Price
$3.12
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
48 days until earnings call
PRME
Price
$4.00
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
44 days until earnings call
Ad is loading...

ADCT vs PRME

Header iconADCT vs PRME Comparison
Open Charts ADCT vs PRMEBanner chart's image
ADC Therapeutics SA
Price$3.12
Change-$0.00 (-0.00%)
Volume$220.59K
CapitalizationN/A
Prime Medicine
Price$4.00
Change-$0.00 (-0.00%)
Volume$834.04K
CapitalizationN/A
View a ticker or compare two or three
ADCT vs PRME Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ADCT vs. PRME commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and PRME is a Hold.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (ADCT: $3.12 vs. PRME: $4.00)
Brand notoriety: ADCT and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 60% vs. PRME: 136%
Market capitalization -- ADCT: $301.54M vs. PRME: $480.12M
ADCT [@Biotechnology] is valued at $301.54M. PRME’s [@Biotechnology] market capitalization is $480.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $609.91B to $0. The average market capitalization across the [@Biotechnology] industry is $3.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 6 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 6 bearish.
  • PRME’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, PRME is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а +6.48% price change this week, while PRME (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.17%. For the same industry, the average monthly price growth was +1.67%, and the average quarterly price growth was -2.02%.

Reported Earning Dates

ADCT is expected to report earnings on Nov 05, 2024.

PRME is expected to report earnings on Nov 01, 2024.

Industries' Descriptions

@Biotechnology (+1.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($480M) has a higher market cap than ADCT($302M). ADCT YTD gains are higher at: 87.952 vs. PRME (-54.853). ADCT has higher annual earnings (EBITDA): -112.43M vs. PRME (-204.68M). ADCT has more cash in the bank: 300M vs. PRME (163M). PRME has less debt than ADCT: PRME (41.6M) vs ADCT (124M). ADCT has higher revenues than PRME: ADCT (66.7M) vs PRME (591K).
ADCTPRMEADCT / PRME
Capitalization302M480M63%
EBITDA-112.43M-204.68M55%
Gain YTD87.952-54.853-160%
P/E RatioN/AN/A-
Revenue66.7M591K11,286%
Total Cash300M163M184%
Total Debt124M41.6M298%
TECHNICAL ANALYSIS
Technical Analysis
ADCTPRME
RSI
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
80%
Bullish Trend 8 days ago
75%
Declines
ODDS (%)
Bearish Trend 21 days ago
90%
Bearish Trend 13 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SRICX12.210.02
+0.16%
Gabelli SRI C
PRPZX8.510.01
+0.12%
PGIM Jennison MLP Z
POLIX46.85N/A
N/A
Polen Growth Institutional
TEMPX8.23N/A
N/A
Nuveen Emerging Markets Eq Prem
GSTRX9.28N/A
N/A
Goldman Sachs Strategic Growth R

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been closely correlated with NTLA. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if PRME jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+6.95%
NTLA - PRME
68%
Closely correlated
+4.83%
BEAM - PRME
65%
Loosely correlated
-0.16%
ABCL - PRME
58%
Loosely correlated
+1.87%
CRSP - PRME
58%
Loosely correlated
+4.46%
ALLO - PRME
56%
Loosely correlated
+4.35%
More